Filing Details
- Accession Number:
- 0001209191-21-026087
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-08 16:57:17
- Reporting Period:
- 2021-04-06
- Accepted Time:
- 2021-04-08 16:57:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1671818 | Oncorus Inc. | ONCR | Pharmaceutical Preparations (2834) | 473779757 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1826523 | Christophe Queva | C/O Oncorus, Inc. 50 Hampshire Street, Suite 401 Cambridge MA 02139 | Cso And Svp, Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2021-04-06 | 5,300 | $15.01 | 77,430 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Shares were sold pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to$15.08 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
Billionaire Hedge Funds
